| Literature DB >> 29027117 |
Mikiko Sakuragi1, Satoru Hayashi1, Miho Maruyama2, Tomoko Kiyokawa1, Keisuke Nagamine1, Jiro Fujita3, Tetsuo Maeda3, Hisashi Kato1,3, Hirokazu Kashiwagi3, Yuzuru Kanakura3, Yoshiaki Tomiyama4,5.
Abstract
We consecutively examined the utility of measurements of percentage of immature platelet fraction (IPF%) and absolute IPF number (A-IPF) in predicting thrombopoietic recovery in 15 adult patients who underwent allogeneic hematopoietic stem cell transplantation (allo-SCT). Four patients were excluded from the evaluation due to insufficient data. Platelet count and IPF were measured by Sysmex XN-1000 (XN), a newer generation analyzer. First, we confirmed that platelet count measured by XN was more accurate than by XE-2100 (XE). IPF measurement was effective to predict the recovery in 7 of the 11 patients examined. Moreover, IPF measurement, especially IPF% measurement, suggested accelerated platelet turnover in two patients who failed to achieve platelet recovery by day 60. In addition to IPF%, A-IPF showed a complementary role on the prediction of thrombopoietic recovery. The increase in IPF% was only transient, while A-IPF values showed lasting increase during platelet recovery. In two patients (cases 6 and 7) an increase in A-IPF, but not in IPF%, was observed during platelet recovery. Our data suggest that IPF% and A-IPF measured by XN are useful for the prediction of thrombopoietic recovery and the assessment of pathogenesis of thrombocytopenia in patients after allo-SCT.Entities:
Keywords: A-IPF; Allo-SCT; Engraftment; IPF%; TMA
Mesh:
Substances:
Year: 2017 PMID: 29027117 DOI: 10.1007/s12185-017-2344-8
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490